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In neurons, the distinct molecular composition of
axons and dendrites is established through polarized
targeting mechanisms, but it is currently unclear how
nonpolarized cargoes, such as mitochondria,
become uniformly distributed over these specialized
neuronal compartments. Here, we show that TRAK
family adaptor proteins, TRAK1 and TRAK2, which
link mitochondria to microtubule-based motors, are
required for axonal and dendritic mitochondrial
motility and utilize different transport machineries
to steer mitochondria into axons and dendrites.
TRAK1 binds to both kinesin-1 and dynein/dynactin,
is prominently localized in axons, and is needed for
normal axon outgrowth, whereas TRAK2 predomi-
nantly interacts with dynein/dynactin, is more abun-
dantly present in dendrites, and is required for
dendritic development. These functional differences
follow from their distinct conformations: TRAK2 pref-
erentially adopts a head-to-tail interaction, which
interferes with kinesin-1 binding and axonal trans-
port. Our study demonstrates how the molecular
interplay between bidirectional adaptor proteins
and distinct microtubule-based motors drives polar-
ized mitochondrial transport.
INTRODUCTION
Transport of mitochondria to meet local energy demands is crit-
ical in highly differentiated and polarized cells such as neurons.
In the axon, mitochondrial ATP production supports the genera-
tion of action potentials and trafficking of synaptic vesicles, and
in dendrites, it is needed for synaptic transmission. Mitochondriaare concentrated in the cell body, which is often far away from
the energy-demanding synapses. Thus, proper targeting ofmito-
chondria from the cell body into dendrites and the axon is essen-
tial for the support of synapses and maintenance of axon and
dendrites. Consistently, defective mitochondrial trafficking and
function are increasingly implicated in neurological diseases
(Chan, 2006; Mattson et al., 2008).
Several studies have shown that cytoskeletal motor proteins
are responsible for transport of mitochondria in neurons
(Boldogh and Pon, 2007; Frederick and Shaw, 2007; Saxton
and Hollenbeck, 2012). In both axons and dendrites, the majority
of these movements are microtubule based and characterized
by alternating outward (or anterograde) and inward (or retro-
grade) transport, interspersed with periods of stationary docking
(Kang et al., 2008; Pilling et al., 2006). Such bidirectional trans-
port suggests that mitochondria interact with both families of
microtubule-based motors, kinesins and dynein, which drive
transport toward the microtubule plus end and minus end,
respectively (Hirokawa and Noda, 2008; Vale, 2003). The regula-
tory mechanism of opposingmotor activities is unknown but is of
obvious importance to deliver mitochondria to the desired
spatiotemporal locations (Saxton and Hollenbeck, 2012). These
opposing motors are also involved in polarized transport and
sorting of specific cargo between axons and dendrites (Kapitein
and Hoogenraad, 2011; Rolls, 2011). In several model systems, it
has been demonstrated that kinesin motors specifically target
the axon and drive synaptic vesicle transport, whereas the
dynein/dynactin motor complex sorts postsynaptic receptors
and Golgi outposts to dendrites (Kapitein et al., 2010a; Zheng
et al., 2008). While two different transport mechanisms exist to
control polarized transport in neurons, it is unclear which
machinery is used to uniformly distribute nonpolarized neuronal
cargos, such as mitochondria.
Genetic screens in Drosophila for synaptic insufficiency have
identified Mitochondrial Rho GTPase (Miro) (Guo et al., 2005)
and trafficking protein, kinesin binding (TRAK)/Milton (Stowers
et al., 2002) as being necessary for mitochondrial transport toNeuron 77, 485–502, February 6, 2013 ª2013 Elsevier Inc. 485
Figure 1. Kinesin-1 and Dynein Drive Polarized Mitochondria Transport in Neurons
(A and B) Hippocampal neurons were cotransfected with mito-dsRed and GFP (control), GFP-KIF5tail, or GFP-p150-cc1 (9 DIV for 4 days), and live-cell imaging
microscopy was used to visualizemitochondrial motility in hippocampal neurons. Kymographs show themotility of mito-dsRed-labeledmitochondria in axons (A)
and dendrites (B). Region of the kymographs in the representative axon or dendrite are indicated above.
(C–F) Quantification of mitochondrial transport in axons and dendrites includes percentage of the number of moving mitochondria (C and D) and number of
mitochondria moving from the soma (E and F). Error bars indicate SEM (*p < 0.05, **p < 0.01, and ***p < 0.001).
(legend continued on next page)
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TRAKs Control Polarized Mitochondrial Transportsynapses. Miro and TRAK are part of a conserved protein
complex that is essential for mitochondrial distribution in
neurons and many other cell types (Boldogh and Pon, 2007;
Goldstein et al., 2008; MacAskill and Kittler, 2010). The TRAKs
act as the motor-adaptor molecules that connect microtubules
via kinesin-1/KIF5 to the mitochondria-anchored protein Miro.
Recent studies showed that the Miro protein serves as a calcium
sensor that regulates kinesin-mediated mitochondrial motility
(Macaskill et al., 2009; Wang and Schwarz, 2009). Whereas
Drosophila carries one TRAK/Milton gene, mammals have two
different TRAK/Milton orthologs, named TRAK1 and TRAK2
(i.e., Milton-1/OIP106 and Milton-2/GRIF-1, respectively) (Brick-
ley et al., 2005). All TRAK/Milton family proteins consist of an
N-terminal coiled-coil region with homology to the huntingtin-
associated protein 1 (HAP1) domain, found in several kinesin
and dynein-interacting proteins, and the C-terminal domain of
TRAK/Milton interacts with Miro (Glater et al., 2006; Stowers
et al., 2002). The high degree of similarity between the mamma-
lian TRAK family members of proteins suggests that they may
have redundant functions; however, this has not previously
been investigated.
Here, we use a large variety of immunohistochemical,
biochemical, cell biological, live-cell imaging, and quantitative
microscopy approaches to demonstrate that TRAK1 and
TRAK2 differentially regulate polarized sorting of mitochondria.
Our data show that TRAK1 binds to both kinesin-1/KIF5B and
dynein/dynactin and steers mitochondria into axons, whereas
TRAK2 predominantly interacts with dynein/dynactin and medi-
ates dendritic targeting. Depletion of TRAK1 reduces axon
outgrowth and branching, whereas TRAK2 knockdown displays
similar defects in dendrites. The difference between the two
TRAK proteins arises from TRAK2’s preference for a folded
conformation, which is inhibitory for the binding to KIF5B and,
hence, for axonal transport. We propose a model in which
kinesin-1 drives mitochondria transport into axons and requires
dynein for its activity (controlled by TRAK1), and dynein
steers mitochondria trafficking into dendrites independently of
kinesin-1 (controlled by TRAK2). Our findings advance the
knowledge of fundamental transport processes essential for
the maintenance of neuronal homeostasis and have important
implications for our understanding of neuronal degeneration.
RESULTS
Polarized Sorting of Mitochondria Is Regulated by
Kinesin-1 and Dynein Motor Proteins
Mitochondria hold different types of motor proteins, and their
opposing activity most likely leads to bidirectional transport in
both axons and dendrites. Recent data demonstrated that(G) PI of cytochrome c (cyt c) intensity in GFP (control), GFP-KIF5-tail, andGFP-p1
SEM. *p < 0.05.
(H) Inducible mitochondria-trafficking assay. Fusions of FRB with the truncated m
(BICDN-FRB) are recruited to FKBP-GFP-mito upon addition of rapalog.
(I and K) Representative images of hippocampal neurons at 15 DIV coexpressing
addition of rapalog. Black arrowheads indicate mitochondria in axons and dendri
after rapalog treatment is indicated (yellow arrowheads). Scale bars, 20 mm.
(J and L) Kymograph of mitochondria movement in axons (J) and dendrites (L) from
See also Figures S1 and S2, Movies S1, S2, S3, S4, and S5, and Table S1.opposing motors are not only required to drive bidirectional
motion but also play an important role in controlling polarized
cargo transport into axon and dendritic processes (Kapitein
and Hoogenraad, 2011; Rolls, 2011). To test whether kinesin-1
and dynein motor activity are required for proper targeting of
mitochondria to axons and dendrites, we used live-cell video
microscopy to visualize mitochondrial motility in hippocampal
neurons (Movie S1 available online) that were transfected with
GFP-tagged dominant-negative kinesin-1 construct (KIF5-tail)
or the dominant-negative dynactin construct (p150-cc1). Mito-
chondria transport parameters in both axons and dendrites
were analyzed using kymographs and tracking software.
Expression of GFP-KIF5-tail in hippocampal neurons results in
a strong reduction of moving mitochondria in the axon, while
motility in dendrites is normal compared to control (Figures 1A
and 1C; Movie S2). In contrast, expression of GFP-p150-cc1
decreased the number of moving mitochondria in both axons
and dendrites (Figures 1A–1D; Movies S2 and S3). In all cases,
the reduced motility is observed in both retrograde and antero-
grade directions in axons and dendrites (Table S1). To specifi-
cally test whether these manipulations can disrupt axonal and
dendritic targeting, we analyzed the number of mitochondria
from the soma that enter these compartments. Axonal targeting
is strongly reduced by blocking KIF5 or dynein/dynactin, while
dendritic entry is only affected by inhibiting dynein/dynactin
activity (Figures 1E and 1F). Analyzing the velocity and run length
of the residual mitochondrial movements in GFP-KIF5-tail
and GFP-p150-cc1-expressing neurons revealed no marked
changes in these dynamic parameters (Figure S1; Table S1).
These results demonstrate that kinesin-1 and dynein strongly
affect the frequency of mitochondria movement, but not the
speed and run length. Moreover, kinesin-1 and dynein cooperate
to control axonal movement, while dendritic motility requires
dynein, but not kinesin-1.
Next, we tested the effect of these manipulations on mito-
chondria distributions in hippocampal neurons. The distribution
of endogenous mitochondria, as revealed by mitochondria
marker cytochrome c, in GFP-KIF5-tail and GFP-p150-cc1-
expressing neurons was dramatically different from controls.
Blocking kinesin-1 redistributed mitochondria away from the
axon into the dendrites, while inhibition of dynein led to a few
more mitochondria in axons. To quantify the mitochondria
dendrite-to-axon ratio, wemeasured the average dendrite inten-
sity (Id) and average axonal intensity (Ia) and calculated the
polarity index (PI) by using PI = (IdIa)/(Id+Ia) (Kapitein et al.,
2010a). For uniformly distributed proteins, Id = Ia and PI = 0,
whereas PI > 0 or PI < 0 indicates polarization toward dendrites
and axons, respectively. Analysis of cytochrome c in control
neurons for the mitochondria distribution yielded a PI of50-cc1-transfected neurons (12 DIV for 2 days) as indicated. Error bars indicate
otor construct of kinesin-1 (KIF5-MDC-FRB) and dynein adaptor Bicaudal D2
FKBP-GFP-mito and KIF5-MDC-FRB (I) and BICDN-FRB (K) before and after
tes. The differential translocation of mitochondria (pseudocolor red) before and
recordings shown in (I) and (K). Green arrows indicates the addition of rapalog.
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Figure 2. TRAK Proteins Are Differentially Distributed in the CNS
(A) Specificity of anti-TRAK antibodies. Lysates from HEK293 cells transfected with YFP-TRAK1 and YFP-TRAK2 analyzed by western blotting with anti-GFP,
anti-TRAK1, or anti-TRAK2 antibodies. YFP refers to the YFP-TRAK-CFP constructs, which runs at150 kDa on immunoblots and allows better separation with
endogenous TRAK proteins (100 kDa).
(legend continued on next page)
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TRAKs Control Polarized Mitochondrial Transport0.22 ± 0.09 (Figure 1G), demonstrating that there are slightly
more mitochondria present in dendrites compared to the axon.
Blocking kinesin-1 reveals a positive PI of 0.62 ± 0.09 (more
abundant in dendrites), while inhibition of dynein shows a PI
of 0.05 ± 0.14 (more in the axon) (Figure 1G), indicating that
kinesin-1 and dynein are necessary for the proper polarized
distribution of mitochondria in axons and dendrites.
Kinesin-1 and Dynein Establish Axon and Dendrite-
Specific Targeting
To directly address whether recruitment of kinesin-1 and dynein
motor activity to mitochondria is sufficient to establish axon and
dendrite-specific targeting, we made use of an inducible mito-
chondria-trafficking assay (Hoogenraad et al., 2003; Kapitein
et al., 2010b). In this assay, FRB-FKBP heterodimerization is
used in combination with the cell-permeable rapamycin analog
AP21967 (from now on called rapalog) to trigger the binding of
the motor proteins of interest to mitochondria. Mitochondria
were labeled by expressing FKBP-GFP-mito, a fusion construct
of the Listeria ActA mitochondria-targeting sequence (mito) to
green fluorescent protein (GFP), and FKBP12, a domain that
can be crosslinked to FRB in the presence of rapalog (Hoogen-
raad et al., 2003) (Figure 1H). FRB is fused to truncated kinesin-1,
which contains the motor domain and coiled-coil dimerization
region (KIF5-MDC-FRB) and the N-terminal part of the dynein/
dynactin accessory protein Bicaudal-D (BICDN-FRB) (Hoogen-
raad et al., 2003; Kapitein et al., 2010b) (Figure 1H). Addition of
rapalog to neurons coexpressing KIF5-MDC-FRB and FKBP-
GFP-mito induced a rapid burst of mitochondria from the cell
body into the axon (Figure 1I; Movie S4). Acquisition of zoomed
regions at increased frame rates (5 frames/s) revealed that the
majority of mitochondria in axons after rapalog addition moved
in anterograde direction (from proximal to distal; Figures 1J,
S2A, and S2C). No mitochondria movement was observed in
dendrites after KIF5-MDC-FRB recruitment (Figures S2A and
S2C). In contrast, addition of rapalog to neurons expressing
BICDN-FRB caused mitochondria to move away from the cell
body into the primary dendrites (Figure 1K; Movie S5). We
observed that mitochondria coupled to dynein target the
dendrites with bidirectional runs (Figures 1L, S2B, and S2D),
which is consistent with dynein-coupled cargos moving into
dendrites along antiparallel microtubules (Kapitein et al.,
2010b). Addition of rapalog to these neurons also drives retro-
grade transport of mitochondria already present in axons(B) Protein extracts of HeLa cells transfectedwith GFP-TRAK1, GFP-TRAK2, and t
western blotting with anti-GFP, anti-TRAK1, or anti-TRAK2 antibodies.
(C) Representative images of hippocampal neurons at DIV14 stained for endoge
Scale bar, 10 mm.
(D) Quantification of TRAK1 and TRAK2 fluorescent-staining intensities in cell bod
shRNAs. The staining is normalized to the nontransfected surrounding cells in th
(E–H) Triple labeling of TRAK1 (red), cytochrome c (green), and DAPI (blue) in CA3
(F–H). The square in (F) corresponds to (H1–H3). TRAK1 antibody is blockedwith it
by the dotted square in (H3). Scale bars, 100 mm.
(I) Western blots of TRAK and KIF5B expression in extracts from cortex (gray ma
(J) Developmental expression patterns of TRAK1 and TRAK2 in E10.5 (whole embr
cerebellum) mouse.
(K) Western blot analysis of TRAK1 and TRAK2 in various adult mouse tissues, in
See also Figure S3.(Figures S2B and S2D). Altogether, these data demonstrate
that the opposing kinesin-1 and dynein motor proteins are both
necessary and sufficient for the proper distribution of mitochon-
dria to axons and dendrites, respectively.
Differential Distribution of TRAK Proteins in the CNS
We hypothesized that regulatory motor-adaptor proteins might
exist that steer mitochondria transport into axons and dendrites.
We focused on the TRAK family because these adaptor proteins
were previously found to associate with kinesin-1 and regulate
mitochondrial transport in neurons (Macaskill et al., 2009;
Wang and Schwarz, 2009). To study the roles of mammalian
TRAK family members in neuronal mitochondrial trafficking, we
first generated rabbit polyclonal antibodies to TRAK1 and
TRAK2 proteins. Both newly generated antibodies reacted
strongly and specifically with the appropriate TRAK protein on
western blot and did not recognize the other TRAK ortholog or
control proteins (Figures 2A and 2B). Antibody specificity was
also demonstrated by immunofluorescence stainings in GFP-
TRAK1/TRAK2-transfected HeLa cells (data not shown). The
TRAK1 and TRAK2 antibodies showed more than 80% reduc-
tion of punctuate-staining intensity in TRAK1 or TRAK2-shRNA-
expressing primary hippocampal neurons, respectively, at
14 days in vitro (DIV14) (Figures 2C, 2D, and S3). Moreover,
the punctate staining in various neuronal cell types in the CNS,
including pyramidal neurons in the hippocampus (Figure 2E),
was blocked by preincubating the antibodies with the corre-
sponding TRAK antigens (Figure 2G; data not shown). The ability
of both TRAK proteins to associate with mitochondria was
confirmed by the colocalization of endogenous TRAK proteins
and cytochrome c (Figure 2C) in mouse brain and spinal cord
sections (Figures 2E–2H). We found 80% (TRAK1) and 70%
(TRAK2) overlap with the mitochondrial marker cytochrome c.
In agreement with in situ hybridization data from the Allen
Mouse Brain Atlas and the immunohistochemical experiments
(Figures 2E–2H), western blot analysis of various adult mouse
tissues showed that both TRAK1 and TRAK2 are expressed
throughout the developing and adult brain (Figure 2J). TRAK2
is predominantly expressed in cerebellum, cortex, and midbrain,
whereas TRAK1 is also detected in several other organs outside
the brain, including heart, liver, lung, and spleen (Figure 2K).
Within the regions of the murine nervous system examined,
TRAK1 and TRAK2 expression varied mostly in the spinal cord
(Figure 2K). In this axon-rich tissue, TRAK1 protein is readilywo negative control constructs (GFP-BICD2 andGFP-KIF17) were analyzed by
nous TRAK1 or TRAK2 (green) and mitochondria marker cytochrome c (red).
y of hippocampal neurons transfected at DIV12 for 4 days with GFP and TRAK-
e same image. ***p < 0.001.
of hippocampus of adult mouse (E) andmotor neurons of the mouse spinal cord
s own antigen in (G). The inset in (H) is an enlarged region of the cell, as indicated
tter) and spinal cord (white matter) of rat.
yo), E13, E16, E18, and P1, P5 (head only), and P10, P15, and adult (forebrain or
cluding brain regions and organs. cerebel., cerebellum; sp. cord, spinal cord.
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Figure 3. Polarized Distribution of TRAK
Proteins in Hippocampal Neurons
(A) Representative images of hippocampal
neurons (DIV 14) stained for endogenous TRAK1
and TRAK2 (green) and costained with Tau and
MAP2 (red) to highlight axon and dendrites. Yellow
arrowheads indicate axons, and blue arrowheads
indicate dendrites. Scale bar, 20 mm.
(B) Representative images of hippocampal neu-
rons (DIV 12+2) cotransfected with GFP-TRAK1 or
GFP-TRAK2 and b-gal to visualize neuronal
morphology. Yellow arrowheads indicate axons,
and blue arrowheads indicate dendrites. Scale
bar, 20 mm.
(C) Quantification of endogenous TRAK1 and
TRAK2 intensity in axons and dendrites of hippo-
campal neurons at DIV 14. Normalized intensity is
the highest fluorescent intensity in axons or
dendrites and set at 100.
(D) PI of endogenous cytochrome c (as control),
TRAK1, and TRAK2 in hippocampal neurons at
DIV 14.
(E) PI of exogenous mitochondria marker mito-
dsRed, GFP-TRAK1, and GFP-TRAK2 in hippo-
campal neurons at DIV 12+ 2.
(F) PI of endogenous cytochrome c intensity in
GFP (as control), GFP-TRAK1, and GFP-TRAK2-
transfected neurons (DIV 12+2).
Error bars indicate SEM. *p < 0.05, **p < 0.01, and
***p < 0.001.
See also Figure S4.
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TRAKs Control Polarized Mitochondrial Transportdetected, whereas TRAK2 protein is barely present, an observa-
tion confirmed by comparing the expression of the two TRAK
proteins in cerebral gray and cervical spinal white matter (Fig-
ure 2I). The low expression of TRAK2 in the spinal cord is unex-
pected for a protein predicted to be involved in axonal transport.
In fact, the axonal transport motor KIF5B is present at higher
levels in the white matter in spinal cord compared to the cortex
(Figure 2I). Together, these data show that both TRAK1 and490 Neuron 77, 485–502, February 6, 2013 ª2013 Elsevier Inc.TRAK2 associate with mitochondria but
have a differential distribution in the CNS.
Polarized Distribution of TRAK
Proteins in Hippocampal Neurons
We next tested whether TRAK1 and
TRAK2 proteins are differentially distrib-
uted in cultured hippocampal neurons.
Although both TRAK1 and TRAK2 anti-
bodies label the neuronal cell body,
axon, and dendrites (Figure 2C), the local-
ization patterns in axons and dendrites
are markedly different from each other.
Double-labeling immunofluorescence
experiments for each TRAK protein and
the axonal marker Tau or the dendritic
marker MAP2 revealed a more prominent
localization of TRAK1 in axons and
TRAK2 in dendrites (Figure 3A). To fur-
ther quantify the differential TRAK1 andTRAK2 distribution in neurons, we measured the average inten-
sity in axon and dendrites (Figure 3C) and calculated the PI.
Quantification of the intensity of TRAK1 antibody staining reveals
a negative PI of 0.32 ± 0.11 (more abundant in axons), while
TRAK2 has a positive PI of 0.68 ± 0.11 (more abundant in
dendrites) (Figure 3D), indicating a polarized distribution of
endogenous TRAK proteins in hippocampal neurons. The
opposing distribution of the two TRAK proteins was even more
Neuron
TRAKs Control Polarized Mitochondrial Transportapparent by expression of fluorescently tagged TRAK1 and
TRAK2: GFP-TRAK1 mainly targeted the axons, while GFP-
TRAK2 was almost exclusively present in dendrites (Figures 3B
and 3E). Interestingly, GFP-TRAK2 is mainly localized to primary
dendrites but is less prominent in higher-order branches. Next,
we investigated whether the expression of TRAK proteins can
influence the normal mitochondrial distribution in neurons.
Neurons transfected with GFP-TRAK1 or GFP-TRAK2 dramati-
cally shifted the mitochondrial localization to axons or dendrites,
respectively (Figure 3F). The opposing effects on mitochondria
localization were also observed in cultured HeLa cells: expres-
sion of GFP-TRAK1 induced formation of peripheral mitochon-
drial clusters, while GFP-TRAK2 caused strong accumulation
of mitochondria in the cell center (Figure S4). Together, these
data show that TRAK1 and TRAK2 have differential effects on
mitochondria distribution: TRAK1 is prominently localized in
axons, while TRAK2 is more abundantly present in dendrites.
TRAK Proteins Control Mitochondrial Motility in Axons
and Dendrites
Recent data suggest that TRAK1 is required for mitochondrial
transport within axons of hippocampal neurons (Brickley and
Stephenson, 2011). To further explore the function of TRAK
proteins inmitochondrial motility, we used live-cell videomicros-
copy and observed that knockdown of TRAK1/TRAK2 disrupts
mitochondrial motility in both axons and dendrites (Figures 4A–
4D; Movies S6 and S7). In the absence of both TRAK proteins,
mitochondrial motility was reduced by 65% in axons and by
45% in dendrites (Figures 4C and 4D). Interestingly, expression
of TRAK1-shRNA in neurons results in a strong reduction of
moving mitochondria in axons compared to control cells (Fig-
ure 4C). In contrast, expression of TRAK2-shRNA does not affect
motility in axons but decreases the number of moving mitochon-
dria in dendrites (Figures 4C and 4D). In all cases, the reduced
motility is observed in both retrograde and anterograde direc-
tions in axons and dendrites (Table S1). Further characterization
of the residual mitochondria dynamics in TRAK knockdown
neurons showed no marked changes in velocity and run length
(Figure S1; Table S1), similar to kinesin-1 and dynein/dynactin
inhibition. Together, these results indicate that TRAK proteins
are important for mitochondrial transport in axons and dendrites:
TRAK1 is required for proper axonal trafficking of mitochondria,
whereas TRAK2 is needed for dendritic mitochondria motility.
TRAK Proteins Are Required for Normal Morphology of
Axons and Dendrites
Given previous observations that dysfunction and defective
transport of mitochondria alter neuronal morphology (Chan,
2006), we examined the effect of TRAK1/TRAK2 knockdown
on the outgrowth of axons and dendrites. In developing neurons
coexpressing TRAK1 and TRAK2 shRNAs and b-galactosidase
(b-gal; to highlight neuronal morphology), we observed amarked
change in morphology of both axons and dendrites (Figure 4E).
Quantification revealed that the length of axons and dendrites
was decreased by 50% in TRAK1/TRAK2 double-knockdown
cells compared to control neurons (Figures 4F–4K). A similar
morphological phenotype was observed after expressing domi-
nant-negative forms of TRAK1 and TRAK2 (Figure S5), whichcontains only the C-terminal Miro-binding domain and inhibits
the binding of endogenous TRAK1/TRAK2 to mitochondria.
We next analyzed single TRAK1 and TRAK2 depletions and
observed that axon morphology of neurons expressing
TRAK1-shRNA was severely affected, while neurons expressing
TRAK2-shRNA showed a marked decrease in dendritic
outgrowth (Figure 4E). Quantification indicated that knockdown
of TRAK1 decreases axon length, the number of axonal tips,
and the number of axonal branches by 50%, compared to
control neurons (Figures 4F–4H). In contrast, knockdown of
TRAK2 decreased total dendritic length and number of primary
dendrites by50%,while the cell soma size was not significantly
changed (Figures 4I–4K). The second set of independent TRAK1
and TRAK2 shRNAs gave similar phenotypes (data not shown).
Together, these results indicate that TRAK proteins are required
for normal neuronal morphology: TRAK1 plays an essential role
in axonal outgrowth, while TRAK2 is critically important for
dendrite morphology.
Differential Interaction of TRAK1 and TRAK2 with
Kinesin-1 and Dynein
To better understand the differential role of TRAK proteins in
mitochondria transport, we next searched for distinct TRAK1
and TRAK2-binding partners. Biotinylated and GFP-tagged
TRAK1 and TRAK2 (bio-GFP-TRAK1 and bio-GFP-TRAK2) and
bio-GFP as a control construct were transiently coexpressed in
HEK293 cells together with the protein-biotin ligase BirA, iso-
lated with streptavidin beads, incubated with rat brain extracts,
and isolated proteins were analyzed by mass spectrometry.
Both bio-GFP-TRAK1 and bio-GFP-TRAK2 bound to the previ-
ously identified TRAK partners, including atypical GTPase Miro
(Miro1 or Miro2) (Glater et al., 2006) and O-linked N-acetylglu-
cosamine (O-GlcNAc) transferase (OGT) (Iyer et al., 2003) (Fig-
ure 5A; Table S2). In addition, potential TRAK-binding partners
were identified, such as several components of dynein and
dynactin complexes, including dynein heavy-chain 1 (DHC1),
dynein light-chain 1 (DLC1), p150Glued, and p50/dynamitin (Fig-
ure 5A). These mass spectrometry results were confirmed by
western blotting (Figure 5B) and immunoprecipitation experi-
ments with GFP-p150Glued (Figure 5C), indicating that both
TRAK1 and TRAK2 bind to the dynein/dynactin motor complex.
To get further insights into the structural features determining the
dynein/dynactin binding to TRAK, we explored whether TRAK
can interact with one distinct subunit in the dynein/dynactin
complex. TRAK1 or TRAK2 was coexpressed with cytoplasmic
dynein and dynactin subunits, and interactions were assessed
by pull-down assays. Both TRAK proteins were precipitated
with the p150Glued subunit of dynactin (Figure 5F), while the
N-terminal tail domain of DHC or the DIC and DLIC subunits of
the dynein complex were negative in this assay. Expression
of GFP-TRAK1 or GFP-TRAK2 revealed colocalization with
dynein/dynactin in HeLa cells, especially in the pericentral region
(Figure 5G; data not shown) and in the cell body of hippocampal
neurons (data not shown). These results indicate that both TRAK
proteins interact with the p150Glued subunit of the dynactin
complex.
Next, we screened the mass spectrometry data for proteins
that showed specific affinity for either TRAK1 or TRAK2 andNeuron 77, 485–502, February 6, 2013 ª2013 Elsevier Inc. 491
Figure 4. TRAK Proteins Are Required for Mitochondrial Motility and Axon and Dendrite Morphology
(A and B) Kymographs show the motility of mitochondria, labeled with mito-dsRed in axons (A) and dendrites (B). Hippocampal neurons were cotransfected with
mito-dsRed and indicated shRNA constructs. Regions of the kymographs in the representative axon or dendrite are indicated.
(legend continued on next page)
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down compared to the TRAK2 pull-down (26 versus 2 unique
KIF5B peptides) (Figure 5A; Table S2). Additional biotin pull-
down and mass spectrometry experiments from other cell lines
also detected a strong enrichment of KIF5B peptides in the
TRAK1 sample (Figure 5B; data not shown). Indeed, endogenous
KIF5B showed higher binding to TRAK1 in coimmunoprecipita-
tion experiments compared to TRAK2, while Miro associated
with both TRAK proteins (Figure 5D). When KIF5B was overex-
pressed, it bound equally well to TRAK1 and TRAK2 (Figures
5E and 5F), suggesting that TRAK2 does not associate with
endogenous kinesin-1 motors, but overexpression can induce
the interaction between TRAK2 and KIF5B. Consistent with
previous data from Glater et al. (2006), we did not find kinesin
light chain (KLC), a major binding partner of kinesin-1, in the
TRAK1 pull-down (Figures 5A and 5B), indicating that the asso-
ciation between TRAK1 and KIF5 does not require KLC.
Together, these data show that TRAK adaptors associate with
a distinct composition of motor complexes; both TRAKs bind
to the dynactin subunit p150Glued, and only TRAK1 shows
a strong interaction with kinesin-1.
Mapping the Binding Region between TRAK1, KIF5B,
and p150Glued
To get further insights into the kinesin-1 and dynein/dynactin
binding to TRAK proteins, we mapped the regions of TRAK1
responsible for KIF5B and p150Glued binding. The NH2
terminus of TRAK1 (amino acids 1–395, TRAK1-N) contains
two predicted coiled-coil domains (Figures S6A and S6B), with
the first one covering amino acids 100–200 and the second
one from 201 to 360. Based on these N-terminal coiled-coil
regions, we produced a series of TRAK1 deletion mutant
constructs (Figure S6C). Full-length GFP-KIF5B or full-length
GFP-p150Glued was coexpressed with different TRAK1 deletion
fragments fused to bio-mCherry in HEK293 cells and immuno-
precipitated using GFP-trap magnetic beads. As expected (Gla-
ter et al., 2006), GFP-KIF5B was coimmunoprecipitated with
TRAK1-N and not TRAK1-C (Figures S6C and S6D). Truncating
TRAK1-N showed that TRAK1_1–360 and TRAK1_101–360
were still efficiently binding to KIF5B, and the shortest binding
region could be reduced down to the second coiled-coil region,
amino acids 201–360 (Figures S6C and S6D). Further shortening
of this region completely abolished binding of KIF5B (data not
shown). The p150Glued interaction required the complete
N-terminal domain (amino acids 1–360) of TRAK1 (Figures S6C
and S6E). Interestingly, GFP-p150Glued was also found to
bind to the C-terminal domain of TRAK1 (TRAK1-C). These
data demonstrate that TRAK proteins contain one N-terminal
KIF5B-binding region and two dynein/dynactin-binding sites,
one at the N-terminal and one at the C-terminal domain.(C and D) Percentage of the number of movingmitochondria in axons (C) and dend
from different imaging recordings.
(E) Representative images of hippocampal neurons cotransfected at DIV 1+4 w
Yellow arrowheads indicate axons, and blue arrowheads highlight some typical
(F–K) Quantification of axon and dendrite morphological parameters of hippocam
axonal branches (H), total dendrite length (I), number of primary dendrites (J), an
Error bars indicate SEM. *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S5 and Movies S6 and S7.The TRAK N-Terminal Domain Mediates Both KIF5B and
Dynein-Dependent Motility
To more directly study the functional interaction between TRAK
proteins and kinesin-1 and dynein/dynactin motors, we again
turned to the inducible cargo-trafficking assay but now used
peroxisomes as a tool to report the cargo transport activity of
TRAK proteins (Kapitein et al., 2010b). Peroxisomes were
labeled by expressing PEX-RFP-FKBP, a fusion construct of
PEX3 peroxisomal membrane-targeting signal to the red fluores-
cent protein (RFP), and FKBP12 (Figure 6A). Since the N-terminal
domain of TRAK binds to both kinesin-1 and dynein/dynactin
(Figure 5), we generated constructs where FRB was fused to
TRAK1-N and TRAK2-N (TRAK1-N-FRB and TRAK2-N-FRB) to
determine whether the N-terminal TRAK fragments can induce
microtubule plus-end and/or minus-end-directed movements.
In COS7 cells transfected with PEX-RFP-FKBP and any of the
two TRAK-N-FRB constructs, most peroxisomes were randomly
distributed, while treating these cells with rapalog revealed
a robust clustering in the cell periphery. Quantification of the
peroxisomal distribution indicated that 40% of the TRAK1-N-
FRB and TRAK2-N-FRB cells showed peripheral peroxisome
clusters, compared to non in control cells (Figures 6I and 6J).
Next, we performed live-cell imaging experiments and confirmed
the directional translocation of peroxisomes to the cell periphery,
similar to KIF5-driven peroxisome motility but also observed
a redistribution of some peroxisomes to more central regions
of the cell, similar to dynein-driven peroxisome movement (Fig-
ure 6B; Movie S8). The average speed and displacement of the
TRAK-N-coupled peroxisomes are markedly lower when
compared to KIF5-MDC-FRB (Figures 6C–6E). Interestingly,
fast acquisition (1 frame/s) to probe motility of individual perox-
isomes revealed that these cargos could move bidirectionally
when attached to TRAK1-N-FRB or TRAK2-N-FRB (Figures
6F–6H). Given that in cells with a radial microtubule array such
as COS7, bidirectional movement is only observed when perox-
isomes are coupled to both kinesin and dynein motors (Kapitein
et al., 2010b), the data suggest that the N-terminal domain of
TRAK mediates both kinesin-1 and dynein/dynactin-dependent
motility.
To further test this, we explored the effect of KIF5B knock-
down and inhibition of dynein/dynactin by HA-p50/dynamitin
on TRAK-N-mediated peroxisomal transport. While in 40%,
control cells expressing TRAK1-N-FRB or TRAK2-N-FRB
peripheral peroxisome clusters were present after rapalog treat-
ment, the peroxisomes shifted to the perinuclear region in90%
of KIF5B-depleted cells (Figure 6J). A similar distribution was
seen when peroxisomes were linked to the DHC-MDC-FRB
(Figure 6B), suggesting that, in the absence of KIF5B, the
minus-end-directed dynein motor complex actively transports
TRAK-N-coupled peroxisomes. Indeed, the tight accumulationrites (D) of control and shRNA-transfected neurons as indicated and calculated
ith indicated shRNA constructs and GFP to visualize the neuron morphology.
dendrites. Scale bar, 20 mm.
pal neurons, including axonal length (F), number of axonal tips (G), number of
d diameter of cell body (K).
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Figure 5. TRAK Proteins Bind to Dynein/Dynactin and Differentially to KIF5B
(A) Binding partners of bio-GFP-TRAK in HEK293 cells loaded with brain extracts and identified by mass spectrometry. acc./Id, accession number/identification
number.
(B) Verification of interactions between TRAK1 or TRAK2 and their endogenous (endo.) binding partners identified by mass spectrometry using biotin pull-down
assay and subsequent western blot analysis. Equal volumes of total pull-down are loaded in each lane. KLC was used as a negative control.
(legend continued on next page)
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expression of HA-p50/dynamitin and resulted in a random
distribution of peroxisomes in both TRAK1-N-FRB and TRAK2-
N-FRB-expressing cells (Figure 6J). Coexpression of myc-
KIF5B redistributed the TRAK-N constructs to the cell periphery
in 70% of the cell (Figure 6J). These data demonstrate that the
N-terminal domain in both TRAK1 and TRAK2 proteins is suffi-
cient to induce microtubule plus-end and minus-end-directed
transport. Interestingly, no significant differences were observed
between TRAK1-N and TRAK2-N in these trafficking experi-
ments, suggesting that additional mechanisms play a role
in regulating the interaction between full-length TRAKs and
kinesin-1.
TRAK2 Folds Back through a Head-to-Tail Interaction
Toexplain thedistinct behaviors of TRAK1andTRAK2,we further
investigated the mechanism underlying the differential binding
of TRAK1 and TRAK2 to kinesin-1. Some motor and adaptor
proteins exist in a folded conformation, which allows the
N-terminal and C-terminal regions to make direct contact and
control their activity (Hirokawa and Noda, 2008). We explored
whether such an intramolecular interaction occurs in TRAK
proteins and could modulate the interaction with kinesin-1. We
first tested whether the head and tail domains of TRAK can
interact by coexpressed GFP-TRAK-N and myc-TRAK-C
constructs in HEK293T cells and found that the two fragments
coimmunoprecipitated with each other, in the case of both
TRAK1 and TRAK2 (Figure 7A). More detailed mapping of the
binding regions showed that the TRAK1-C interaction required
the complete N-terminal domain (amino acids 1–360) of TRAK1
(Figures S6C and S6F), while further shortening of this region
completely abolished binding of TRAK1-C (data not shown).
Next, we reasoned that attaching fluorophores to the NH2 and
COOH termini of TRAK proteins (CFP donor and YFP acceptor)
would allow us to detect fluorescence resonance energy transfer
(FRET) if TRAK proteins indeed fold back and the NH2 and
COOH termini come in close proximity. We generated TRAK1
and TRAK2 fusion constructs with YFP at the NH2 terminus
and CFP at the COOH terminus (YFP-TRAK1-CFP and YFP-
TRAK2-CFP) and used three different methods to determine
the N- and C-terminal interacts, including FRET measurements
in extracts, fluorescence lifetime imaging microscopy (FLIM),
and acceptor photobleaching in single cells. First, HEK293T cells
were transfected with plasmids, expressing CFP and YFP (nega-
tive control), CFP-YFP tandem fusion (positive control), YFP-
TRAK1-CFP, or YFP-TRAK2-CFP, and the fluorescence spectra
of the resulting cell extracts were measured (Lansbergen et al.,
2004). Cell extracts containing both CFP and YFP displayed no
significant emission of the YFP acceptor after the excitation of
the CFP donor, while CFP-YFP displayed marked sensitized(C–E) Immunoprecipitations (IP) using GFP antibodies from extracts of HEK2
myc-GRASP-1 (control) and probed for GFP or myc (C), GFP-TRAK1, GFP-TRAK2
myc-KIF5B and indicated GFP-TRAK constructs and probed for myc or GFP (E)
(F) Biotin pull-downs (PD) from HEK293 extracts transfected with myc-TRAK1
probed for GFP/HA and myc. The ratio input/pellet is 2%–5% for all pull-down a
(G) HeLa cells transfected with GFP-TRAK2 and stained with anti-p150Glued. Ma
Scale bar, 10 mm.
See also Figure S6 and Table S2.YFP fluorescence after CFP excitation due to FRET (Figure 7B,
blue arrowhead). A marked YFP-sensitized emission was
displayed by the YFP-TRAK2-CFP and less by the YFP-
TRAK1-CFP-containing cell extract (Figure 7B, red and green
arrowheads). The occurrence of FRET in the extract containing
the YFP-TRAK2-CFP fusion is indicated by the 20% higher
ratio of fluorescence at 527 nm (YFP emission) to fluorescence
at 475 nm (CFP emission) upon excitation at 425 nm, as
compared with CFP + YFP mixture (Figure 7B). In contrast,
YFP-TRAK1-CFP showed a small, nonsignificant fluorescent
increase at 527 nm in this assay (Figure 7B). The ratio of YFP-
to-CFP fluorescence in the extract, containing YFP-TRAK2-
CFP protein, did not change after it was diluted, suggesting
that the binding between the TRAK2 head and tail was intramo-
lecular and not intermolecular (data not shown).
Next, we performed FRET measurements using FLIM in fixed
(Figure 7D) and live COS7 cells (Figures 7C and 7E) expressing
the constructs described above. FRET was detected by the
decrease in CFP lifetime when YFP was in close proximity. As
expected, cells expressing YFP-CFP tandem showed clear
decrease in CFP lifetime compared to cells expressing CFP
alone or with plasmidmixture of CFP+ YFP. Next, we determined
FRET signals in cells expressing YFP-TRAK1-CFP or YFP-
TRAK2-CFP and found that the TRAK2 construct showed
a significantly higher FRET efficiency (Figure 7D). Similar data
are obtained in live cells (Figures 7C and 7E). These results
were confirmed by acceptor photobleaching approaches, where
bleaching of YFP in YFP-CFP-positive FRET pairs dequenches
CFP fluorescence and results in increased CFP fluorescence.
With this method, only YFP-TRAK2-CFP showed a significant
increase in CFP fluorescence intensity (Figure 7G). In all these
experiments, TRAK2 consistently displays a significant FRET
signal, suggesting an intramolecular association between the
N- to C-terminal domains of the molecule. We believe that
TRAK2 forms a relatively stabile head-to-tail interaction, while
folding of full-length TRAK1 is more dynamic, short lived, and
transient, suggesting that some properties of TRAK1 preclude
its efficient self-folding.
Conformational Changes in TRAKRegulate KIF5Binding
and Mitochondrial Sorting
While TRAK2 did not associate with endogenous KIF5B, but
overexpression of myc-KIF5B could force an interaction (Fig-
ure 5), we reasoned that the folded TRAK2 conformation might
compete with endogenous kinesin-1 binding and that high
concentrations of KIF5B might release the inhibitory state by
unfolding TRAK2. Extracts prepared from cells cotransfected
with myc-KIF5B and YFP-TRAK2-CFP, in the absence or
presence of the TRAK-binding partner Miro (myc-Miro), no
longer displayed a significant FRET signal, while YFP-sensitized93 cells transfected with GFP-p150Glued and myc-TRAK1, myc-TRAK2 or
or GFP (control) and probed for endogenous KIF5B, myc-Miro-1 and GFP (D),
.
or myc-TRAK2 and indicated biotin-tagged dynein/dynactin constructs and
nd immunoprecipitation experiments.
gnified areas show accumulation of p150Glued in the pericentrosomal region.
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Figure 6. The TRAK N-Terminal Domain Mediates Bidirectional Motility
(A) Inducible cargo-trafficking assay. Fusions of FRB with truncated TRAK fragment (TRAK-N-FRB) are recruited to PEX-RFP-FKBP upon addition of rapalog.
(legend continued on next page)
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YFP-TRAK2-CFP alone, or YFP-TRAK2-CFP together with myc-
Miro (Figure 7B; data not shown). Moreover, pull-down experi-
ments comparing TRAK1-N only and TRAK1-N/TRAK1-C
complexes indicate that a reduced amount of KIF5B is precipi-
tated in the presence of TRAK1-C (Figure S6G), consistent
with the idea that the intramolecular interaction in TRAK proteins
and TRAK binding to KIF5B are mutually exclusive.
If the ‘‘open’’ TRAK conformation correlates with KIF5B
binding, while the ‘‘closed’’ conformation inhibits it, forcing
TRAK1 to fold back might make it more similar to TRAK2 and
allow translocation from the axon to dendrites. To test this
idea, we again used the rapamycin-mediated FRB-FKBP heter-
odimerization system but now fused the FRB and FKBP
domains to the NH2 terminus and COOH terminus of TRAK1
and TRAK2 (FRB-HA-TRAK1-FKBP and FRB-HA-TRAK2-
FKBP), respectively, causing a tight interaction between the
C-terminal and N-terminal parts of TRAK after rapalog addition
(Figure 8A). We first tested the system in HeLa cells by express-
ing FRB-HA-TRAK1-FKBP or FRB-HA-TRAK2-FKBP and treat-
ing cells with rapalog for different time periods (0, 15, and
30 min). Already 15 min after the addition of rapalog, the number
of FRB-HA-TRAK1-FKBP cells with a pericentral TRAK1 locali-
zation shifted from 10% (control 0 min rapalog) to 60% (Fig-
ure 8C), suggesting a change in balance from plus-end-directed
to minus-end-directed transport. No marked effect was ob-
served in cell expressing FRB-HA-TRAK2-FKBP. Next, neurons
were transfected with FRB-HA-TRAK1-FKBP or FRB-HA-
TRAK2-FKBP constructs and treated with rapalog for different
periods of time: 0, 30 min, and 2 hr. In control situation (0 min
rapalog), the localization of TRAK1 and TRAK2 in axons and
dendrites was similar to that described before. However, the
addition of rapalog for 30 min caused a marked translocation
of TRAK1 from the axonal compartment to the dendritic
branches (Figure 8D), while TRAK2 maintained its dendritic
distribution (data not shown). The change in PI reflects the
strong enrichment of TRAK1 in dendrites (Figure 8E). The lack
of KIF5B binding with the rapalog-induced ‘‘closed’’ conforma-
tion of FRB-HA-TRAK1-FKBP was confirmed by immunoprecip-
itation experiments, while the binding for dynein/dynactin was
unaffected (Figure 8B). Together, these data strongly indicate
that conformational differences between TRAK proteins control
motor binding and regulate polarized mitochondrial sorting in
neurons.(B) Peroxisome distribution before and after rapalog addition in the presence of TR
MDC-FRB) or DHC (DHC-MDC-FRB). Yellow lines indicate COS7 cell outline.
kymographs for the recordings are indicated in right panel.
(C) Time traces of R90% for cells transfected with the KIF5-MDC-FRB (n = 9; bla
DHC-MDC-FRB (n = 8; blue line). Sigmoid curves were fitted. Note that R90% is th
(D) Graph shows the average speed of peroxisomes as calculated from time trac
(E) Graph shows peroxisome displacement 15 min after addition of rapalog.
(F–H) Time series shows translocation of TRAK2-N-FRB-mediated cargo after add
and (H) are shown in a kymograph (G). Bidirectional motion is observed after TR
(I) Schematic overview of the three distribution patterns observed in HeLa cell
peripheral (black), or pericentral (blue) accumulations.
(J) Percentage of HeLa cells shows dispersed, pericentrosomal, or peripheral dis
TRAK2-N and triple transfection with KIF5B siRNA, myc-KIF5B, or HA-p50 cons
See also Movie S8.DISCUSSION
Complex processes critical for neuronal polarization have adapt-
ed basic cellular pathways to achieve the functional specializa-
tion of axons and dendrites. Some of these processes, such as
cargo trafficking, require additional layers of control and signifi-
cant fine-tuning. Here, we describe a molecular mechanism
that efficiently coordinates mitochondrial transport in neurons.
We demonstrate that the TRAK family proteins are bidirectional
motor adaptors that differ in their function to transport mitochon-
dria into axons and dendrites. TRAK1 binds to both kinesin-1 and
dynein/dynactin, is prominently localized in axons, and is
required for axonal outgrowth, whereas TRAK2 predominantly
interacts with dynein/dynactin, is more abundantly present in
dendrites, and is required for dendritic development. Moreover,
we show that the differential function of the TRAK proteins can
be explained by conformational differences. Our data suggest
that TRAK2 adopts a folded conformation through an associa-
tion between its NH2 and COOH termini, which inhibits the
binding to kinesin-1 and prevents axonal transport.
Mammalian TRAK Proteins Control Mitochondria
Trafficking in Polarized Cells
Previous work examining the role of motor proteins in axonal
mitochondrial transport revealed that the opposite-polarity
motors kinesin-1 and dynein drive anterograde and retrograde
transport, respectively (Boldogh and Pon, 2007; Frederick and
Shaw, 2007; Saxton and Hollenbeck, 2012). In many models,
targeting of mitochondria depends on kinesin-1’s ability to over-
come the opposing effect of dynein, and understanding motor
protein regulation has become a key challenge to interpret retro-
grade versus anterograde motility. It is clear that the activity of
both opposite-polarity motors triggers bidirectional transport,
which is most likely regulated by cargo-adaptor proteins (Welte,
2004). Here, we show that kinesin-1 and dynein/dynactin coop-
erate to control trafficking of mitochondria in the axon. Inhibition
of kinesin-1 or dynein alone reduced motility in both retrograde
and anterograde directions, consistent with detailed genetic
analysis of mitochondrial movement in Drosophila larval motor
axons (Pilling et al., 2006). This is in agreement with other model
systems where kinesin-1 and cytoplasmic dynein require each
other for bidirectional transport of intracellular cargo (Ally et al.,
2009). In contrast, we show that mitochondria motility in
dendrites only requires dynein motor activity, which is consistentAK1-N-FRB, TRAK2-N-FRB, the truncatedmotor construct of kinesin-1 (KIF5-
The overlay of sequential binarized images is color coded by time. Radial
ck line), TRAK1-N-FRB (n = 5; green line), TRAK2-N-FRB (n = 9; red line), and
e radius for each time point that includes 90% of the total fluorescent intensity.
es of R90%.
ition of rapalog within 33 s (F) and 5 s (H). Scale bars, 5 mm. The recordings in (F)
AK2-N recruitment to the peroxisome.
s using the peroxisome-based trafficking assay; random distribution (white),
tribution of PEX-GFP alone compared to double transfection with TRAK1-N, or
tructs.
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Figure 7. Intramolecular Head-to-Tail Interactions in TRAK2 Measured by FRET in Living Cells
(A) Coimmunoprecipitations from extracts of HEK293 cells cotransfected with indicated constructs.
(legend continued on next page)
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Figure 8. Conformational Changes in TRAK Proteins Regulate Mitochondrial Sorting
(A) Schematic overview of FRB-rapalog-FKBP system used to induce folding of TRAK proteins.
(B) Immunoprecipitations using HA antibodies from extracts of HeLa cells transfected with FRB-HA-TRAK1-FKBP and treated with (+) or without () rapalog for
10 min.
(C) Representative images of transfected HeLa cells with FRB-HA-TRAK1-FKBP before (0 min) and after (30 min) addition of rapalog. The number of cells with
a pericentral TRAK1 localization shifted from 10% to 60% within this time frame (p < 0.05; n = 3 independent experiment). Scale bar, 10 mm.
(D) Representative images of hippocampal neurons at DIV 12+2 transfected with FRB-HA-TRAK1-FKBP before (0 min) and after (30 min and 2 hr) addition of
rapalog. Scale bar, 10 mm.
(E) PI of FRB-HA-TRAK1-FKBP in hippocampal neurons at DIV 12+2 before (0min) and after (30min and 2 hr) addition of rapalog. Three independent experiments
(n > 15 neurons) were performed. Error bars indicate SEM. ***p < 0.001.
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TRAKs Control Polarized Mitochondrial Transportwith dynein-only-coupled cargos moving in a bidirectional
fashion along antiparallel dendritic microtubules (Kapitein
et al., 2010b).
Recent work has also revealed that, in addition to bidirectional
transport, kinesin-1 and dynein/dynactin proteins play important
roles in selective trafficking into axons and dendrites (Kapitein
and Hoogenraad, 2011). Studies in both Drosophila and
mammalian neurons indicated that kinesin-1 motors, often in
concert with dynein (Kwinter et al., 2009; Pilling et al., 2006),
drive transport into the axon, while the dynein/dynactin complex
is the key motor for selective transport into dendrites (Kapitein
et al., 2010a; Zheng et al., 2008). The axonal targeting of kine-
sin-1 is governed by microtubule modifications that enhance
kinesin-1 binding, whereas dynein-dependent cargo sorting to(B) Emission spectrums of the extracts prepared from HEK293 cells transfected w
corresponding controls (including YFP +CFP [black line] and YFP-CFP tandem [bl
arbitrary units.
(C) COS7 cells were transfected with indicated constructs. The lifetime of CFP w
tandem FRET construct as positive control. The lifetimes are presented in pseud
(D and E) Statistical analysis of FRET efficiency for fixed (D) and living (E) COS7 c
were measured per group. Error bars indicate SEM. *p < 0.05; **p < 0.01; ***p <
(F) Acceptor bleaching FRET of indicated constructs in COS7 cells. Pre- and post
acceptor (YFP) is indicated in white circle. CFP intensity images are presented in
(G) Quantification of FRET acceptor bleaching (AB) efficiency. CFP intensities in th
as mean FRET AB efficiency. Between 10 and 31 cells were measured per groupdendrites is facilitated by the minus-end distal-oriented microtu-
bules exclusively present in dendrites (Kapitein et al., 2010a;
Rolls, 2011). Our data demonstrate that kinesin-1 motors drive
mitochondria transport into axons and require dynein/dynactin
for their activity, while dynein/dynactin steers mitochondria traf-
ficking into dendrites independently of kinesin-1. The strong and
opposite targeting preferences of these mitochondrial transport
motors in axons and dendrites suggest that establishing nonpo-
larized transport of mitochondria requires fine-tuning of dynein
and kinesin-1 motor protein activity. Our data suggest that
mammalian TRAK1 and TRAK2 differentially employ these two
transport machineries and together mediate selective mitochon-
drial trafficking in polarized cells. We propose a model in which
kinesin-1 drives mitochondria transport into axons and requiresith TRAK1 (green line) or TRAK2 (red line) constructs fused to YFP and CFP or
ue line]), measuredwith excitation at 425 nm. Fluorescence intensity is shown in
as measured and compared to YFP + CFP as negative control and YFP-CFP
ocolor scale (2–3.5 ns range).
ells transfected with the constructs represented in (C). Between 6 and 12 cells
0.001.
bleached images of YFP and CFP channels are depicted. Bleached area of the
pseudocolor scale (0–255).
e bleached area were measured before and after bleaching of YFP and plotted
. Error bars indicate SEM. *p < 0.05; **p < 0.01. n.s., not significant.
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TRAKs Control Polarized Mitochondrial Transportdynein for its activity (controlled by TRAK1), and dynein
steers mitochondria trafficking into dendrites independently of
kinesin-1 (controlled by TRAK2).
Several lines of evidence support this model. First, we show
that TRAK1 and TRAK2 have a polarized distribution in hippo-
campal neurons. TRAK1 is prominently localized in axons, while
TRAK2 is more abundantly present in dendrites. Second,
increased TRAK1 expression levels drive mitochondria in the
axon, while overexpression of TRAK2 leads to the accumulation
of mitochondria in dendrites. These opposing effects were also
observed in nonneuronal cells, where TRAK1 expression
exhibits a more peripheral localization, and TRAK2 shows
a central localization. Third, TRAK1 and TRAK2 associate with
different motor protein complexes: TRAK1 binds to both kine-
sin-1 and dynein/dynactin, while TRAK2 predominantly interacts
with dynein/dynactin. This suggests that TRAK2 is predomi-
nately linked to minus-end-directed transport motors, which
makes it an ideal candidate for targeting mitochondria to
dendrites. We propose that TRAK2 controls transport of mito-
chondria from the cell body into dendrites by promoting dynein
binding. Consistently, our data show that dynein/dynactin is
required for the proper dendritic distribution of mitochondria
and that direct coupling of dynein to mitochondria drives their
transport into dendrites. Once mitochondria are inside axons
or dendrites, the final targeting, such as to synapses, could be
achieved through selective retention at target sites (Kang et al.,
2008) or specific delivery by additional actin-dependent motors
such as myosin V (Saxton and Hollenbeck, 2012).
Conformational Differences between TRAK Proteins
Govern Mitochondrial Trafficking
Our data support the motor-adaptor model forDrosophilaMilton
that proposes that linkage of mitochondria to the transport
machinery involves Milton/TRAK adaptors that bind to microtu-
bule-based motors (Boldogh and Pon, 2007; Goldstein et al.,
2008; MacAskill and Kittler, 2010). Expression of Milton in
HEK293 cells also showed clustering of mitochondria near the
microtubule-organizing center (Stowers et al., 2002), suggesting
that Drosophila Milton might interact with components of the
dynein/dynactin complex. Moreover, several Milton splice vari-
ants have been described in flies that differentially bind to
kinesin-1 (Glater et al., 2006). The splice variant Milton-C shows
remarkable similarities with TRAK2: it induces pericentrosomal
accumulation of mitochondria and binds relatively poorly to kine-
sin-1 (Glater et al., 2006).
To explain the functional differences between TRAK1 and
TRAK2, we propose that TRAK2 proteins change their protein
conformation as a result of interaction of the N-terminal coiled-
coil region and C-terminal domain, thereby affecting the interac-
tion with KIF5B. Our data demonstrate that the intramolecular
TRAK2 interaction and KIF5B binding are mutually exclusive.
Thus, only when the N-terminal TRAK2 domain detaches from
the C-terminal tail domain does this N-terminal region become
available for kinesin-1 binding. The binding of TRAK2 to themito-
chondrial adaptor Miro and to components of the dynein/
dynactin complex is not dependent on TRAK protein folding.
Therefore, TRAK2-enriched mitochondria will predominantly
contain dynein/dynactin and subsequently drive mitochondria500 Neuron 77, 485–502, February 6, 2013 ª2013 Elsevier Inc.into the dendrites. In contrast, TRAK1 is largely precluded from
efficient self-folding, interacts with KIF5, and drives mitochon-
dria into axons. Induced folding of TRAK1 by using the FRB-
rapalog-FKBP system makes it behave similar to TRAK2 and
promotes its translocation from the axon to dendrites. Consis-
tent with the data that folded TRAK conformations compete
with kinesin-1 binding, the rapalog-induced ‘‘closed’’ TRAK1
does not longer bind to KIF5B, while the interaction with
dynein/dynactin is unaffected.
Mitochondria in axon and dendrite have both TRAK proteins
and opposing motors on them in both compartments. This
implies that concentration differences of TRAK1 and TRAK2 on
mitochondria can balance the transport in either the anterograde
or retrograde direction and subsequently steers mitochondria
trafficking to axons or dendrites. Mitochondria with higher
TRAK2 levels have a higher chance to be transported by dynein,
while mitochondria on which TRAK1 is more abundant are more
frequently transported by kinesin-1. This differential transport
also explains why more TRAK1 accumulates in axons and
more TRAK2 in dendrites; the polarized TRAK pools can further
promote differential transport of mitochondria within the two
neuronal compartments. However, this is probably not the
complete picture. TRAK1 and TRAK2 can most likely, at least
partly, compensate for each other’s function. For example,
TRAK1 can form an N- and C-terminal interaction and show
FRET signals in single-cell assays, and TRAK1 knockdown
reveals a mild dendrite morphology phenotype with some traf-
ficking defects. Moreover, knockdown of TRAK1/TRAK2 and
inhibition of dynein/dynactin and kinesin-1 do not completely
stop mitochondrial motility but inhibit axonal and dendritic trans-
port about 2- to 3-fold. Therefore, it is expected that additional
motor proteins but also coordinating factors and signaling
proteins will participate in regulating bidirectional movements
and polarized mitochondria transport in neurons. Recent work
characterized Miro’s role as a calcium sensor for the regulation
of mitochondrial dynamics and bidirectional transport (Macaskill
et al., 2009; Russo et al., 2009; Wang and Schwarz, 2009) and
found a role for O-GlcNAc OGT (Brickley et al., 2011; Iyer
et al., 2003) and PINK1 (Liu et al., 2012; Wang et al., 2011) in
controlling mitochondrial dynamics. Moreover, it is tempting to
speculate that conformational switching of TRAK proteins is an
additional mechanism for local motor protein regulation. Addi-
tional studies are required to determine whether other adaptor/
motor complexes participate in mitochondria transport and
whether local signaling can influence polarized trafficking.
In this study, we established a key role for mammalian TRAK
proteins in axonal and dendritic targeting of mitochondria. We
found that TRAK proteins are important for uniformmitochondria
distribution in polarized cells and both axon and dendritic
morphology. Expression of individual TRAK proteins changes
the distribution of mitochondria in axons or dendrites. Alterations
in mitochondrial transport have been described in kinesin and
dynein mutant mice (Tanaka et al., 1998; Wiggins et al., 2012)
and are correlated with several neurodegenerative diseases
(Chan, 2006; Mattson et al., 2008). Our current findings provide
molecular targets to investigate the axonal and dendritic mito-
chondrial transport machinery in neurodegenerative disease
models. Future studies using genetic disease mouse models
Neuron
TRAKs Control Polarized Mitochondrial Transportwill help to elucidate the mechanisms regulating the molecular
interplay between motors, bidirectional adaptor and polarized




cDNAs encoding human TRAK1 (amino acids 754–953) and TRAK2 (amino
acids 848–913) were cloned into pGEX-4T to generate glutathione S-trans-
ferase (GST) fusion proteins. Rabbit anti-TRAK1 and anti-TRAK2 antibodies
were generated by immunizing rabbits with GST-TRAK fusion proteins. Details
of TRAK antisera and other antibodies and reagents are in the Supplemental
Experimental Procedures.
DNA Constructs
The TRAK1 and TRAK2 expression constructs and their deletion mutants
were generated by a PCR-based strategy using the human TRAK1 cDNA
(KIAA1042, a gift from Kazusa DNA Research Institute) and human TRAK2
cDNA (IMAGE clone 4814594). The TRAK1#1 (50-GCTGTCGCAAATCGTGGA
CTT-30), TRAK1#2 (50-GTGTACTGCCTTAACGACT-30), TRAK2#1 (50-GC
TTGTCACATCAAGACAGAA-30), and TRAK2#2 (50-CGCTACATGATTCTA
GGCA-30) sequences targeting rat TRAK1 mRNA (NM_001042646.1) and
TRAK2 mRNA (NM_015049.1) were designed by using the siRNA selection
program at the Whitehead Institute for Biomedical Research. For details, see
Supplemental Experimental Procedures.
Primary Hippocampal Neuron Cultures and Transfection
Primary hippocampal cultures were prepared from embryonic day 18 (E18) rat
brains and transfected using Lipofectamine 2000 (Invitrogen).
Image Acquisition, Processing, and Morphometric Analyses
Simultaneous dual-color time-lapse live-cell imaging and TIRFM were per-
formed on aNikon Eclipse TE2000Emicroscopewith CoolSNAP andQuantEM
cameras (Roper Scientific). Neurons were maintained at 37C with 5% CO2
(Tokai Hit). FRET-FLIM measurements on fixed and living cells expressing
YFP and CFP fused to the NH2 and COOH terminus of TRAKs and corre-
sponding controls were performed on a PCM-2000 Confocal microscope
equipped with a time-gated fluorescence lifetime imaging module (LiMo;
Nikon Instruments). FRET acceptor photobleaching experiments were per-
formed on SP5 CLSM systems (Leica-Microsystems). For details, see
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, two tables, eight movies, and
Supplemental Experimental Procedures and can be found with this article on-
line at http://dx.doi.org/10.1016/j.neuron.2012.11.027.
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